Bafna Pharmaceuticals Ltd.
BSE: 532989 | Sector: Health care |
NSE: BAFNAPH | ISIN Code: INE878I01022 |
BSE 00:00 | 13 Apr | 127.25 |
-6.65 (-4.97%) |
OPEN
127.25 |
HIGH
132.75 |
LOW
127.25 |
NSE 00:00 | 13 Apr | 127.20 |
-3.20 (-2.45%) |
OPEN
123.90 |
HIGH
134.85 |
LOW
123.90 |
OPEN | 127.25 |
PREVIOUS CLOSE | 133.90 |
VOLUME | 3119 |
52-Week high | 195.95 |
52-Week low | 10.24 |
P/E | 105.17 |
Mkt Cap.(Rs cr) | 301 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bafna Pharmaceuticals Ltd. (BAFNAPH) - Announcements
-
Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
13/04/2021 | bse
-
Bafna Pharmaceuticals Ltd Sub: Compliance Certificate For The Half Year Ended 31St March 2021
09/04/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Sub.:- Clarification On Price Movement
18/03/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Clarification sought from Bafna Pharmaceuticals Ltd
18/03/2021 | bse
-
Bafna Pharmaceuticals Ltd Outcome Of The Board Meeting Held On 12Th February 2021
12/02/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Outcome Of Board Meeting
12/02/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Board Meeting Intimation for To Inter Alia Consider And Adopt Un-Audited Financial Results For The Q
02/02/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) R
20/01/2021 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2020
13/01/2021 | bse
-
Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
13/01/2021 | bse
-
Bafna Pharmaceuticals Ltd Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
24/12/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
12/11/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
12/11/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Results For The Quarter Ending 30Th Sep 2020
12/11/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Board Meeting Intimation for Quarterly Results And Other Business With The Permission Of The Chair.
02/11/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Sub: Certificate From Practicing Company Secretary For The Half Year Ended 30Th September 2020<BR>
23/10/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Shareholding for the Period Ended September 30 2020
20/10/2020 | bse
-
Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended September 2020
19/10/2020 | bse
-
Bafna Pharmaceuticals Ltd Sub: Compliance Certificate For The Half Year Ended 30Th September 2020
13/10/2020 | bse |
Downlaod PDF
-
Bafna Pharmaceuticals Ltd Clarification
23/09/2020 | bse |
Downlaod PDF
Quick Links for Bafna Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices